Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015

Press/Media: Press / Media

PeriodMay 30 2015 → May 31 2015

Media coverage

9

Media coverage

  • TitlePhase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015
    Media name/outletRed Orbit
    CountryUnited States
    Date5/31/15
    PersonsRuben Mesa
  • TitlePhase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015
    Media name/outletTutorial Finder
    CountryUnited States
    Date5/30/15
    PersonsRuben Mesa
  • TitlePhase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015
    Media name/outletReview Seeker
    CountryUnited States
    Date5/30/15
    PersonsRuben Mesa
  • TitlePhase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015
    Media name/outletUSA Life Sciences Database
    CountrySwitzerland
    Date5/30/15
    PersonsRuben Mesa
  • TitlePhase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015
    Media name/outletFinancial Content
    CountryUnited States
    Date5/30/15
    PersonsRuben Mesa
  • TitlePhase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015
    Media name/outletBiotechgate
    CountrySwitzerland
    Date5/30/15
    PersonsRuben Mesa
  • TitlePhase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015
    Media name/outletAsian Hospital & Healthcare Management
    CountryIndia
    Date5/30/15
    PersonsRuben Mesa
  • TitlePhase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015
    Media name/outletPipelineReview
    CountrySpain
    Date5/30/15
    PersonsRuben Mesa
  • TitlePhase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015
    Media name/outletPharmacy Choice
    CountryUnited States
    Date5/30/15
    PersonsRuben Mesa